7
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Autologus Stem Cell Transplantation as Postremission Therapy for Acute Myeloid Leukemia. Risk Factors at Diagnosis can Predict the Outcome

, , , , &
Pages 1083-1085 | Published online: 01 Jul 2009

  • Estey, E.H. (2001) "Therapeutic options for acute myelogenous leukemia", Cancer 92, 1059 - 1073
  • Gorin, N.C. (1998) "Autologus stem cell transplantation in acute myelocytic leukemia", Blood 92, 1073 - 1090
  • Burnett, A.K. (1998) "Transplantation in first remission acute myeloid leukemia", NEJM 339 (23), 1698 - 1700
  • Harousseau, J.L., Cahn, J.Y., Pignon, B., et al. (1997) "Comparison of autologus bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute leukemia. The GOELAM", Blood 90, 2978 - 2986
  • Cassileth, G.A., Harrington, D.P., Appelbaum, F.R., et al. (1998) "Chemotherapy compared with autologus or allogenic bone marrow transplantation in the management of acute myeloid leukemia in first remission", N. Engl. J. Med. 339, 1649 - 1656
  • Reiifers, J., Labopin, M. and Sanz, M. (2000) "Autologus cells vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis", Bone Marrow Transplant. 25, 1115 - 1119
  • Burnett, A.K. (2001) "Evaluating the contribution of allogenic and autologus transplantation to the management of acute myeloid leukemia in adults", Cancer Chemother. Pharmacol. Suppl. 1, 53 - 58
  • Mandelli, F., Petti, M.C. and Lo Coco, F. (1998) "Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach", Haematologica 10, 1015 - 1023
  • Slovak, M.L., Kopecky, K.J., Cassileth, P.A., et al. (2000) "Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study", Blood 96, 4075 - 4083
  • Visani, G., Lemoli, R.M., Tosi, P., et al. (1999) "Use of pheripheral blood stem cells for autologus transplantation in acute myeloid leukemia patients allow faster engraftment and equivalent disease-free survival compared with bone marrow cells", Bone Marrow Transplant. 24, 467 - 472

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.